These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1584741)

  • 21. Analysis of T helper cell responses during infection with Leishmania amazonensis.
    Ji J; Sun J; Qi H; Soong L
    Am J Trop Med Hyg; 2002 Apr; 66(4):338-45. PubMed ID: 12164286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice.
    Gessner A; Blum H; Röllinghoff M
    Immunobiology; 1993 Dec; 189(5):419-35. PubMed ID: 8125519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-through identification of T cell-specific phage-exposed mimotopes using PBMCs from tegumentary leishmaniasis patients and their use as vaccine candidates against Leishmania amazonensis infection.
    Carvalho GB; Costa LE; Lage DP; Ramos FF; Santos TTO; Ribeiro PAF; Dias DS; Salles BCS; Lima MP; Carvalho LM; Dias ACS; Alves PT; Franklin ML; Silva RAM; Duarte MC; Menezes-Souza D; Roatt BM; Chávez-Fumagalli MA; Goulart LR; Teixeira AL; Coelho EAF
    Parasitology; 2019 Mar; 146(3):322-332. PubMed ID: 30198459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization with antigenic extracts of Leishmania associated with Montanide ISA 763 adjuvant induces partial protection in BALB/c mice against Leishmania (Leishmania) amazonensis infection.
    Cargnelutti DE; Salomón MC; Celedon V; García Bustos MF; Morea G; Cuello-Carrión FD; Scodeller EA
    J Microbiol Immunol Infect; 2016 Feb; 49(1):24-32. PubMed ID: 24662018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Partial protective responses induced by a recombinant cysteine proteinase from Leishmania (Leishmania) amazonensis in a murine model of cutaneous leishmaniasis.
    Fedeli CE; Ferreira JH; Mussalem JS; Longo-Maugéri IM; Gentil LG; dos Santos MR; Katz S; Barbiéri CL
    Exp Parasitol; 2010 Feb; 124(2):153-8. PubMed ID: 19735658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T-cell responses to immunodominant LACK antigen do not play a critical role in determining susceptibility of BALB/c mice to Leishmania mexicana.
    Torrentera FA; Glaichenhaus N; Laman JD; Carlier Y
    Infect Immun; 2001 Jan; 69(1):617-21. PubMed ID: 11119565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Despite increased CD4+Foxp3+ cells within the infection site, BALB/c IL-4 receptor-deficient mice reveal CD4+Foxp3-negative T cells as a source of IL-10 in Leishmania major susceptibility.
    Nagase H; Jones KM; Anderson CF; Noben-Trauth N
    J Immunol; 2007 Aug; 179(4):2435-44. PubMed ID: 17675505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A role for gamma delta + T cells during experimental infection of mice with Leishmania major.
    Rosat JP; MacDonald HR; Louis JA
    J Immunol; 1993 Jan; 150(2):550-5. PubMed ID: 8419488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility to Leishmania mexicana infection is due to the inability to produce IL-12 rather than lack of IL-12 responsiveness.
    Rodriguez-Sosa M; Monteforte GM; Satoskar AR
    Immunol Cell Biol; 2001 Aug; 79(4):320-2. PubMed ID: 11488977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+ T cells.
    Aseffa A; Gumy A; Launois P; MacDonald HR; Louis JA; Tacchini-Cottier F
    J Immunol; 2002 Sep; 169(6):3232-41. PubMed ID: 12218142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The histopathological and immunological pattern of CBA mice infected with Leishmania amazonensis after treatment with pyrazole carbohydrazide derivatives.
    Charret KS; Lagrota-Cândido J; Carvalho-Pinto CE; Hottz CF; Lira ML; Rodrigues RF; Gomes AO; Bernardino AM; Canto-Cavalheiro MM; Leon LL; Amaral VF
    Exp Parasitol; 2013 Feb; 133(2):201-10. PubMed ID: 23219949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the Thy-1 pathway of T cell hybridoma activation using 17 rat monoclonal antibodies reactive with distinct Thy-1 epitopes.
    Pont S; Regnier-Vigouroux A; Naquet P; Blanc D; Pierres A; Marchetto S; Pierres M
    Eur J Immunol; 1985 Dec; 15(12):1222-8. PubMed ID: 2417861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo administration of anti-murine CD3 monoclonal antibody induces selective, long-term anergy in CD8+ T cells.
    Woodle ES; Hussein S; Bluestone JA
    Transplantation; 1996 Mar; 61(5):798-803. PubMed ID: 8607186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proliferative capacity of senescent lymphocytes. II. Monoclonal antibody stimulation of mucosal and systemic lymphocytes via T cell activation molecules, CD3 epsilon, T cell receptor V beta 8 chain, and phosphatidylinositol-linked anchored receptors THY-1 and LY-6A.2/TAP.
    Green-Johnson JM; Szewczuk MR
    Reg Immunol; 1990-1991; 3(6):323-35. PubMed ID: 1983438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation by anti-CD2 monoclonal antibody of the activation of a human T cell clone induced by anti-CD3 or anti-T cell receptor antibodies.
    Yssel H; Aubry JP; de Waal Malefijt R; de Vries JE; Spits H
    J Immunol; 1987 Nov; 139(9):2850-5. PubMed ID: 2444643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoregulatory pathways in murine leishmaniasis: different regulatory control during Leishmania mexicana mexicana and Leishmania major infections.
    Alexander J; Kaye PM
    Clin Exp Immunol; 1985 Sep; 61(3):674-82. PubMed ID: 3907906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late cutaneous metastases in C3H SCID mice infected with Leishmania amazonensis.
    Vanloubbeeck Y; Ackermann MR; Jones DE
    J Parasitol; 2005 Feb; 91(1):226-8. PubMed ID: 15856912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of iron superoxide dismutase-encoding DNA vaccine on the evolution of the Leishmania amazonensis experimental infection.
    Campos BL; Silva TN; Ribeiro SP; Carvalho KI; Kallás EG; Laurenti MD; Passero LF
    Parasite Immunol; 2015 Aug; 37(8):407-16. PubMed ID: 26040192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of an antigen from Leishmania amazonensis amastigotes able to elicit protective responses in a murine model.
    Beyrodt CG; Pinto AR; Freymüller E; Barbiéri CL
    Infect Immun; 1997 Jun; 65(6):2052-9. PubMed ID: 9169731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of signaling by IL-4 or by IL-4/IL-13 has more attenuating effects on Leishmania amazonensis dorsal skin--than on footpad-infected mice.
    Felizardo TC; Gaspar-Elsas MI; Lima GM; Abrahamsohn IA
    Exp Parasitol; 2012 Jan; 130(1):48-57. PubMed ID: 22019418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.